European Growth Orifarm is pursuing expansive growth across Europe under new leadership, creating opportunities for cross-border supply agreements and multi-country distribution partnerships with manufacturers and wholesalers.

Cost Efficient Portfolio Its core focus on parallel imports and low-cost generics suggests opportunities to broaden its pharmaceutical portfolio, optimize sourcing, and pursue private-label or exclusive distribution arrangements with manufacturers.

Compliance and Tech A strong emphasis on regulatory governance and compliance, including NIS2, EXTEDO, and PRINCE2, indicates these are ripe areas for integrated regulatory management, cyber security enhancements, and data-driven supply chain analytics.

Channel Expansion With a diverse customer base including wholesalers, pharmacies, hospitals and patients, there is potential to digitize procurement, deploy supplier portals and tender solutions, and strengthen hospital-channel distribution.

Strategic Partnerships Orifarm’s history with large asset deals and strategic collaborations signals openness to co-development, portfolio moves, and manufacturing or distribution partnerships to accelerate growth.